Association between metabolic syndrome and risk of benign prostatic hyperplasia: a prospective cohort study of 163 975 participants
Journal of Global Health · 03.10.2025 · 15
DOI: 10.7189/jogh.15.04275 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Journal of Global Health, online erschienen am 03.10.2025. Verfasst von Jiaming He und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, The Third Xiangya Hospital of Central South University, Changsha, China. Hauptthemen laut MEDLINE: Metabolic Syndrome, Prostatic Hyperplasia. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Urology, The Third Xiangya Hospital of Central South University, Changsha, China.
- Department of Andrology, The First Hospital of Hunan University of Chinese Medicine, Changsha, China.
Zitieren
APA
He, J., Pan, X., Liu, D., Li, J., Li, Y., Wang, Y., Guo, J., Zhou, Q., Zhou, L., & Wang, L. (2025). Association between metabolic syndrome and risk of benign prostatic hyperplasia: a prospective cohort study of 163 975 participants. Journal of Global Health, 15. https://doi.org/10.7189/jogh.15.04275
Vancouver
He J, Pan X, Liu D, Li J, Li Y, Wang Y, et al. Association between metabolic syndrome and risk of benign prostatic hyperplasia: a prospective cohort study of 163 975 participants. Journal of Global Health. 2025;15. doi:10.7189/jogh.15.04275
BibTeX
@article{He2025,
author = {He, Jiaming and Pan, Xinkai and Liu, Dingwen and Li, Jiaren and Li, Youyou and Wang, Yichuan and Guo, Jinjing and Zhou, Qing and Zhou, Liang and Wang, Long},
title = {Association between metabolic syndrome and risk of benign prostatic hyperplasia: a prospective cohort study of 163 975 participants},
journal = {Journal of Global Health},
year = {2025},
volume = {15},
doi = {10.7189/jogh.15.04275}
}
EUVIMED